With tailor-made nanocarriers, we will set new standards for the targeted, efficient and low-risk use of active pharmaceutical ingredients and other highly potent substances for medical and life science applications.
OUR VISION
We save human lives
by targeted use of highly potent substances
We rethink therapy
via tailor-made nanocarriers for efficiency and safety
We treat the untreatable
e.g. septic liver failure
NEWS
16th February 2026
FIT FOR THE FUTURE: APPLICATION DAY AT CARL-ZEISS GYMNASIUM JENA
Last Friday, SmartDyeLivery once again actively participated in the application training program for 11th grade students at Carl Zeiss Gymnasium in Jena. In short, simulated job interviews, students received individual feedback and were able to ask questions about career paths and entry opportunities.
RUBIN ALLIANCE ATHANA: INTERVIEW ON BMFTR WEBSITE ONLINE
On behalf of the Federal Ministry of Education and Research (BMFTR), the funding body for the RUBIN Alliance ATHANA, Dr. Marc Lehmann and Dr. Christoph Englert were interviewed. Together, they explain the goals, current status, and challenges of the research alliance in the fight against fungal infections.
BMFTR RESEARCH CAMPUS INITIATIVE: JOINT PROJECT APPROVED
In fall 2025, the jury of the BMFTR Research Campus Initiative approved the third phase of the InfectoGnostics Research Campus, with SmartDyeLivery as an industry partner. Since October 2025, the campus partners have been working on seven new lead projects for diagnostic solutions of the future.
At the kick-off on January 14, 2026, at the Center for Applied Research in Jena, SmartDyeLivery and its partners provided an insight into the planned research work. ...
